Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Edit functionality is currently unavailable.

Sagar Uday Nigwekar, M.D.

Title
Institution
Department
Address
Phone
Profile Picture

Biography
2012 - 2014
Clinical Scientist in Nephrology-American Kidney Fund
2013 - 2014
Sanofi Nephrology Fellowship Award
2014 - 2015
Young Investigator Award-National Kidney Foundation
2014 - 2015
Fund for Medical Discovery Clinical Fellowship- MGH Executive Committee on Research (ECOR)
2014 - 2014
Leslie S.T. Fang Excellence in Clinical Nephrology Award
2016 - 2016
Alexander Leaf Excellence in Research Award

Overview

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. U01DK123818 (Sahir Kalim and Sagar Nigwekar) Sep 24, 2019 - May 31, 2024
    NIH/NIDDK
    Reducing chronic pain and opioid use in hemodialysis patients
    Role: MPI
  2. Carl W. Gottschalk Research Scholar Grant (Sagar Nigwekar) Jul 1, 2019 - Jun 30, 2021
    American Society of Nephrology Foundation for Kidney Research
    Novel Determinants of Calcific Uremic Arteriolopathy
  3. Pilot Translational Research Grant (Sagar Nigwekar and Rajeev Malhotra) Mar 1, 2019 - Mar 31, 2021
    MGH Department of Medicine
    Autophagy as a Novel Determinant of Calciphylaxis
    Role: Co-PI
  4. CMeRIT Award (Sagar Nigwekar) Oct 1, 2015 - Sep 30, 2017
    Harvard Catalyst
    Role of Vitamin K in Calcific Uremic Arteriolopathy
    Role: PI
  5. 15FTF25980003 (Sagar Nigwekar) Jul 1, 2015 - Jun 30, 2020
    American Heart Association
    Evaluating the Role of Vitamin K in Calcific Uremic Arteriolopathy
    Role: PI

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Chaudet KM, Dutta P, Nigwekar SU, Nazarian RM. Calciphylaxis-Associated Cutaneous Vascular Calcification in Noncalciphylaxis Patients. Am J Dermatopathol. 2020 Aug; 42(8):557-563. PMID: 32701689.
    Citations:    
  2. Gabel CK, Nguyen ED, Dobry AS, Baker O, Garza-Mayers AC, Ko LN, Shah R, St John J, Strazzula L, Nigwekar SU, Kroshinsky D. Assessment of outcomes of calciphylaxis lesions treated with intralesional sodium thiosulfate. J Am Acad Dermatol. 2020 Jul 28. PMID: 32735974.
    Citations:    
  3. Ayus JC, Fuentes N, Go AS, Achinger SG, Moritz ML, Nigwekar SU, Waikar SS, Negri AL. Chronicity of Uncorrected Hyponatremia and Clinical Outcomes in Older Patients Undergoing Hip Fracture Repair. Front Med (Lausanne). 2020; 7:263. PMID: 32695787.
    Citations:    
  4. Adamsick ML, Gandhi RG, Bidell MR, Elshaboury RH, Bhattacharyya RP, Kim AY, Nigwekar S, Rhee EP, Sise ME. Remdesivir in Patients with Acute or Chronic Kidney Disease and COVID-19. J Am Soc Nephrol. 2020 07; 31(7):1384-1386. PMID: 32513665.
    Citations:    
  5. Gabel C, Chakrala T, Shah R, Danesh MJ, Dobry AS, Garza-Mayers AC, Ko LN, Nguyen E, St John J, Walls AC, Nigwekar SU, Song PI, Kroshinsky D. Penile calciphylaxis: A retrospective case-control study. J Am Acad Dermatol. 2020 May 15. PMID: 32422224.
    Citations:    
  6. Lyu H, Zhao SS, Yoshida K, Tedeschi SK, Xu C, Nigwekar SU, Leder BZ, Solomon DH. Delayed Denosumab Injections and Bone Mineral Density Response: An Electronic Health Record-based Study. J Clin Endocrinol Metab. 2020 May 01; 105(5). PMID: 31894244.
    Citations:    
  7. Musso CG, Enz PA, Kowalczuk A, Cozzolino M, Brandenburg V, Nigwekar S. Differential diagnosis of calciphylaxis in chronic dialysis patients. Int Urol Nephrol. 2020 Mar; 52(3):595-597. PMID: 32008200.
    Citations:    
  8. Olaniran KO, Allegretti AS, Zhao SH, Achebe MM, Eneanya ND, Thadhani RI, Nigwekar SU, Kalim S. Kidney Function Decline among Black Patients with Sickle Cell Trait and Sickle Cell Disease: An Observational Cohort Study. J Am Soc Nephrol. 2020 02; 31(2):393-404. PMID: 31810990.
    Citations:    
  9. Olaniran KO, Seethapathy H, Zhao SH, Allegretti AS, Kalim S, Nigwekar SU. Validity of International Classification of Diseases Codes for Sickle Cell Trait and Sickle Cell Disease. J Gen Intern Med. 2020 Apr; 35(4):1323-1324. PMID: 31745854.
    Citations:    
  10. Nigwekar SU, Pai AB, Mueller B, Dean MC, Costello G, Sherman CR. Impact of hemodialysis on the concentrations of sodium and potassium during infusion of sodium thiosulfate using an In Vitro hemodialysis model. PLoS One. 2019; 14(11):e0224767. PMID: 31721800.
    Citations:    
  11. Nigwekar SU. Cardiovascular Calcifications Among Patients With Uremia: Answers to Hard Questions. Adv Chronic Kidney Dis. 2019 11; 26(6):407-408. PMID: 31831118.
    Citations:    
  12. Lyu H, Zhao SS, Yoshida K, Tedeschi SK, Xu C, Nigwekar SU, Leder BZ, Solomon DH. Comparison of Teriparatide and Denosumab in Patients Switching From Long-Term Bisphosphonate Use. J Clin Endocrinol Metab. 2019 11 01; 104(11):5611-5620. PMID: 31265071.
    Citations:    
  13. Malhotra R, Mauer AC, Lino Cardenas CL, Guo X, Yao J, Zhang X, Wunderer F, Smith AV, Wong Q, Pechlivanis S, Hwang SJ, Wang J, Lu L, Nicholson CJ, Shelton G, Buswell MD, Barnes HJ, Sigurslid HH, Slocum C, Rourke CO, Rhee DK, Bagchi A, Nigwekar SU, Buys ES, Campbell CY, Harris T, Budoff M, Criqui MH, Rotter JI, Johnson AD, Song C, Franceschini N, Debette S, Hoffmann U, Kälsch H, Nöthen MM, Sigurdsson S, Freedman BI, Bowden DW, Jöckel KH, Moebus S, Erbel R, Feitosa MF, Gudnason V, Thanassoulis G, Zapol WM, Lindsay ME, Bloch DB, Post WS, O'Donnell CJ. HDAC9 is implicated in atherosclerotic aortic calcification and affects vascular smooth muscle cell phenotype. Nat Genet. 2019 11; 51(11):1580-1587. PMID: 31659325.
    Citations:    
  14. Seethapathy H, Nigwekar SU. Revisiting therapeutic options for calciphylaxis. Curr Opin Nephrol Hypertens. 2019 09; 28(5):448-454. PMID: 31169527.
    Citations:    
  15. Nigwekar SU, Negri AL, Bajpai D, Allegretti A, Kalim S, Seethapathy H, Bhan I, Murthy K, Ayus JC. Chronic prolonged hyponatremia and risk of hip fracture in elderly patients with chronic kidney disease. Bone. 2019 10; 127:556-562. PMID: 31362067.
    Citations:    
  16. Dutta P, Chaudet KM, Nazarian RM, Kroshinsky D, Nigwekar SU. Correlation between clinical and pathological features of cutaneous calciphylaxis. PLoS One. 2019; 14(6):e0218155. PMID: 31194797.
    Citations:    
  17. Lyu H, Jundi B, Xu C, Tedeschi SK, Yoshida K, Zhao S, Nigwekar SU, Leder BZ, Solomon DH. Comparison of Denosumab and Bisphosphonates in Patients With Osteoporosis: A Meta-Analysis of Randomized Controlled Trials. J Clin Endocrinol Metab. 2019 05 01; 104(5):1753-1765. PMID: 30535289.
    Citations:    Fields:    
  18. Shah NB, Allegretti AS, Nigwekar SU, Kalim S, Zhao S, Lelouvier B, Servant F, Serena G, Thadhani RI, Raj DS, Fasano A. Blood Microbiome Profile in CKD : A Pilot Study. Clin J Am Soc Nephrol. 2019 05 07; 14(5):692-701. PMID: 30962186.
    Citations:    
  19. Lyu H, Yoshida K, Tedeschi SK, Zhao S, Xu C, Nigwekar SU, Leder BZ, Solomon DH. Intervals between bone mineral density testing with dual-energy X-ray absorptiometry scans in clinical practice. Osteoporos Int. 2019 Apr; 30(4):923-927. PMID: 30680429.
    Citations:    Fields:    
  20. Seethapathy H, Nigwekar SU. Medication Prescription Patterns for Secondary Hyperparathyroidism: More Questions than Answers. Clin J Am Soc Nephrol. 2019 02 07; 14(2):178-179. PMID: 30665921.
    Citations:    Fields:    
  21. Cozzolino M, Mangano M, Galassi A, Ciceri P, Messa P, Nigwekar S. Vitamin K in Chronic Kidney Disease. Nutrients. 2019 Jan 14; 11(1). PMID: 30646590.
    Citations:    Fields:    
  22. Allegretti AS, Vela Parada X, Ortiz GA, Long J, Krinsky S, Zhao S, Fuchs BC, Sojoodi M, Zhang D, Karumanchi SA, Kalim S, Nigwekar SU, Thadhani RI, Parikh SM, Chung RT. Serum Angiopoietin-2 Predicts Mortality and Kidney Outcomes in Decompensated Cirrhosis. Hepatology. 2019 02; 69(2):729-741. PMID: 30141205.
    Citations:    Fields:    
  23. Seethapathy H, Brandenburg VM, Sinha S, El-Azhary RA, Nigwekar SU. Review: update on the management of calciphylaxis. QJM. 2019 Jan 01; 112(1):29-34. PMID: 30304522.
    Citations:    Fields:    Translation:Humans
  24. Kale G, Jeloka T, Shrividya S, Mulay A, Deshmukh M, Krishnan S, Nigwekar S. Calciphylaxis in a renal transplant recipient with normal graft function: A case report and review of literature. Saudi J Kidney Dis Transpl. 2019 Jan-Feb; 30(1):215-220. PMID: 30804284.
    Citations:    
  25. Garlo KG, Steele DJR, Nigwekar SU, Chan KE. Demystifying the Benefits and Harms of Anticoagulation for Atrial Fibrillation in Chronic Kidney Disease. Clin J Am Soc Nephrol. 2019 01 07; 14(1):125-136. PMID: 30593489.
    Citations:    Fields:    
  26. Portales-Castillo I, Kroshinsky D, Malhotra CK, Culber-Costley R, Cozzolino MG, Karparis S, Halasz CL, Goverman J, Manley HJ, Malhotra R, Nigwekar SU. Calciphylaxis-as a drug induced adverse event. Expert Opin Drug Saf. 2019 01; 18(1):29-35. PMID: 30574812.
    Citations:    Fields:    
  27. Blaha T, Nigwekar S, Combs S, Kaw U, Krishnappa V, Raina R. Dermatologic manifestations in end stage renal disease. Hemodial Int. 2019 01; 23(1):3-18. PMID: 30520561.
    Citations:    Fields:    
  28. Olaniran KO, Eneanya ND, Nigwekar SU, Vela-Parada XF, Achebe MM, Sharma A, Thadhani RI. Sickle Cell Nephropathy in the Pediatric Population. Blood Purif. 2019; 47(1-3):205-213. PMID: 30517931.
    Citations:    Fields:    
  29. Williams EA, Moy AP, Cipriani NA, Nigwekar SU, Nazarian RM. Factors associated with false-negative pathologic diagnosis of calciphylaxis. J Cutan Pathol. 2019 Jan; 46(1):16-25. PMID: 30280393.
    Citations:    Fields:    
  30. Olaniran KO, Percy SG, Zhao S, Blais C, Jackson V, Kamdar MM, Goverman J, Kroshinsky D, Temel JS, Nigwekar SU, Eneanya ND. Palliative Care Use and Patterns of End-of-Life Care in Hospitalized Patients With Calciphylaxis. J Pain Symptom Manage. 2019 02; 57(2):e1-e3. PMID: 30399415.
    Citations:    Fields:    
  31. Nigwekar SU, Thadhani R. Long-Term Anticoagulation for Patients Receiving Dialysis. Circulation. 2018 10 09; 138(15):1530-1533. PMID: 30354526.
    Citations:    Fields:    
  32. Garza-Mayers AC, Shah R, Sykes DB, Nigwekar SU, Kroshinsky D. The Successful Use of Apixaban in Dialysis Patients with Calciphylaxis Who Require Anticoagulation: A Retrospective Analysis. Am J Nephrol. 2018; 48(3):168-171. PMID: 30176675.
    Citations:    Fields:    
  33. Nigwekar SU, Nazarian RM. Cutaneous calcification in patients with kidney disease is not always calciphylaxis. Kidney Int. 2018 08; 94(2):244-246. PMID: 30031445.
    Citations:    Fields:    Translation:Humans
  34. Huang B, Li Z, Wang Y, Xia J, Shi T, Jiang J, Nolan MT, Li X, Nigwekar SU, Chen L. Effectiveness of self-management support in maintenance haemodialysis patients with hypertension: A pilot cluster randomized controlled trial. Nephrology (Carlton). 2018 Aug; 23(8):755-763. PMID: 28666310.
    Citations:    Fields:    
  35. Bajaj R, Courbebaisse M, Kroshinsky D, Thadhani RI, Nigwekar SU. Calciphylaxis in Patients With Normal Renal Function: A Case Series and Systematic Review. Mayo Clin Proc. 2018 09; 93(9):1202-1212. PMID: 30060958.
    Citations:    Fields:    
  36. Nigwekar SU, Thadhani R, Brandenburg VM. Calciphylaxis. N Engl J Med. 2018 07 26; 379(4):399-400. PMID: 30044942.
    Citations:    Fields:    Translation:Humans
  37. Lin B, Srikanth P, Castle AC, Nigwekar S, Malhotra R, Galloway JL, Sykes DB, Rajagopal J. Modulating Cell Fate as a Therapeutic Strategy. Cell Stem Cell. 2018 09 06; 23(3):329-341. PMID: 29910150.
    Citations:    Fields:    
  38. Nigwekar SU, Thadhani R, Brandenburg VM. Calciphylaxis. N Engl J Med. 2018 May 03; 378(18):1704-1714. PMID: 29719190.
    Citations: 2     Fields:    Translation:Humans
  39. Dobry AS, Ko LN, St John J, Sloan JM, Nigwekar S, Kroshinsky D. Association Between Hypercoagulable Conditions and Calciphylaxis in Patients With Renal Disease: A Case-Control Study. JAMA Dermatol. 2018 02 01; 154(2):182-187. PMID: 29238798.
    Citations:    
  40. St John J, Vedak P, Garza-Mayers AC, Hoang MP, Nigwekar SU, Kroshinsky D. Location of skin lesions in Henoch-Schönlein purpura and its association with significant renal involvement. J Am Acad Dermatol. 2018 Jan; 78(1):115-120. PMID: 29241772.
    Citations: 1     Fields:    Translation:Humans
  41. Zheng K, Wang H, Hou B, You H, Yuan J, Luo K, Chen L, Li M, Xu Q, Zhu Y, Cui L, Nigwekar SU, Feng F, Li X. Malnutrition-inflammation is a risk factor for cerebral small vessel diseases and cognitive decline in peritoneal dialysis patients: a cross-sectional observational study. BMC Nephrol. 2017 Dec 20; 18(1):366. PMID: 29262796.
    Citations: 1     Fields:    Translation:Humans
  42. Nigwekar SU, Jiramongkolchai P, Wunderer F, Bloch E, Ichinose R, Nazarian RM, Thadhani RI, Malhotra R, Bloch DB. Increased Bone Morphogenetic Protein Signaling in the Cutaneous Vasculature of Patients with Calciphylaxis. Am J Nephrol. 2017; 46(5):429-438. PMID: 29130990.
    Citations: 1     Fields:    Translation:HumansCells
  43. Hao J, Li Y, Zhang X, Pang C, Wang Y, Nigwekar SU, Qiu L, Chen L. The prevalence and mortality of hyponatremia is seriously underestimated in Chinese general medical patients: an observational retrospective study. BMC Nephrol. 2017 Oct 31; 18(1):328. PMID: 29089024.
    Citations:    Fields:    Translation:Humans
  44. Isakova T, Nickolas TL, Denburg M, Yarlagadda S, Weiner DE, Gutiérrez OM, Bansal V, Rosas SE, Nigwekar S, Yee J, Kramer H. KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Am J Kidney Dis. 2017 12; 70(6):737-751. PMID: 28941764.
    Citations: 11     Fields:    
  45. Nigwekar SU, Weiser JM, Kalim S, Xu D, Wibecan JL, Dougherty SM, Mercier-Lafond L, Corapi KM, Eneanya ND, Holbrook EH, Brown D, Thadhani RI, Paunescu TG. Characterization and Correction of Olfactory Deficits in Kidney Disease. J Am Soc Nephrol. 2017 Nov; 28(11):3395-3403. PMID: 28775001.
    Citations:    Fields:    Translation:Humans
  46. Nigwekar SU. Calciphylaxis. Curr Opin Nephrol Hypertens. 2017 07; 26(4):276-281. PMID: 28375870.
    Citations: 2     Fields:    Translation:Humans
  47. Fan X, Kalim S, Ye W, Zhao S, Ma J, Nigwekar SU, Chan KE, Cui J, Cai J, Wang L, Heng W, Zhou Y, Sun Y, Cui R, Zhang W, Wang B, Dai Q, Li X, Thadhani R, Li X. Urinary Stone Disease and Cardiovascular Disease Risk in a Rural Chinese Population. Kidney Int Rep. 2017 Nov; 2(6):1042-1049. PMID: 29270513.
    Citations: 1     
  48. Nigwekar SU, Bloch DB, Nazarian RM, Vermeer C, Booth SL, Xu D, Thadhani RI, Malhotra R. Vitamin K-Dependent Carboxylation of Matrix Gla Protein Influences the Risk of Calciphylaxis. J Am Soc Nephrol. 2017 Jun; 28(6):1717-1722. PMID: 28049648.
    Citations: 7     Fields:    Translation:Humans
  49. Paul S, Rabito CA, Vedak P, Nigwekar SU, Kroshinsky D. The Role of Bone Scintigraphy in the Diagnosis of Calciphylaxis. JAMA Dermatol. 2017 01 01; 153(1):101-103. PMID: 26677101.
    Citations: 5     Fields:    Translation:Humans
  50. Zhang Y, Corapi KM, Luongo M, Thadhani R, Nigwekar SU. Calciphylaxis in peritoneal dialysis patients: a single center cohort study. Int J Nephrol Renovasc Dis. 2016; 9:235-241. PMID: 27698566.
    Citations: 2     
  51. Nigwekar SU, Kang A, Zoungas S, Cass A, Gallagher MP, Kulshrestha S, Navaneethan SD, Perkovic V, Strippoli GF, Jardine MJ. Interventions for lowering plasma homocysteine levels in dialysis patients. Cochrane Database Syst Rev. 2016 May 31; (5):CD004683. PMID: 27243372.
    Citations: 2     Fields:    Translation:Humans
  52. Nigwekar SU, Sprague SM. We Do Too Many Parathyroidectomies for Calciphylaxis. Semin Dial. 2016 07; 29(4):312-4. PMID: 27082830.
    Citations: 1     Fields:    Translation:Humans
  53. Nigwekar SU, Zhao S, Wenger J, Hymes JL, Maddux FW, Thadhani RI, Chan KE. A Nationally Representative Study of Calcific Uremic Arteriolopathy Risk Factors. J Am Soc Nephrol. 2016 Nov; 27(11):3421-3429. PMID: 27080977.
    Citations: 12     Fields:    Translation:Humans
  54. Ayus JC, Fuentes NA, Negri AL, Moritz ML, Giunta DH, Kalantar-Zadeh K, Nigwekar SU, Thadhani RI, Go AS, De Quiros FG. Mild prolonged chronic hyponatremia and risk of hip fracture in the elderly. Nephrol Dial Transplant. 2016 10; 31(10):1662-9. PMID: 27190372.
    Citations: 4     Fields:    Translation:Humans
  55. Lundquist AL, Nigwekar SU. Optimal management of bone mineral disorders in chronic kidney disease and end stage renal disease. Curr Opin Nephrol Hypertens. 2016 Mar; 25(2):120-6. PMID: 26785065.
    Citations: 1     Fields:    Translation:Humans
  56. Nigwekar SU. Multidisciplinary approach to calcific uremic arteriolopathy. Curr Opin Nephrol Hypertens. 2015 Nov; 24(6):531-7. PMID: 26371529.
    Citations: 4     Fields:    Translation:Humans
  57. Lloyd WR, Agarwal S, Nigwekar SU, Esmonde-White K, Loder S, Fagan S, Goverman J, Olsen BR, Jumlongras D, Morris MD, Levi B. Raman spectroscopy for label-free identification of calciphylaxis. J Biomed Opt. 2015 Aug; 20(8):80501. PMID: 26263412.
    Citations: 3     Fields:    Translation:Humans
  58. Nigwekar SU, Kroshinsky D, Nazarian RM, Goverman J, Malhotra R, Jackson VA, Kamdar MM, Steele DJ, Thadhani RI. Calciphylaxis: risk factors, diagnosis, and treatment. Am J Kidney Dis. 2015 Jul; 66(1):133-46. PMID: 25960299.
    Citations: 31     Fields:    Translation:HumansAnimals
  59. Kang A, Nigwekar SU, Perkovic V, Kulshrestha S, Zoungas S, Navaneethan SD, Cass A, Gallagher MP, Ninomiya T, Strippoli GF, Jardine MJ. Interventions for lowering plasma homocysteine levels in kidney transplant recipients. Cochrane Database Syst Rev. 2015 May 04; (5):CD007910. PMID: 25938479.
    Citations:    Fields:    Translation:Humans
  60. Bhan I, Dobens D, Tamez H, Deferio JJ, Li YC, Warren HS, Ankers E, Wenger J, Tucker JK, Trottier C, Pathan F, Kalim S, Nigwekar SU, Thadhani R. Nutritional vitamin D supplementation in dialysis: a randomized trial. Clin J Am Soc Nephrol. 2015 Apr 07; 10(4):611-9. PMID: 25770176.
    Citations: 20     Fields:    Translation:Humans
  61. Nigwekar SU, Solid CA, Ankers E, Malhotra R, Eggert W, Turchin A, Thadhani RI, Herzog CA. Quantifying a rare disease in administrative data: the example of calciphylaxis. J Gen Intern Med. 2014 Aug; 29 Suppl 3:S724-31. PMID: 25029979.
    Citations: 10     Fields:    Translation:Humans
  62. Allegretti AS, Nazarian RM, Goverman J, Nigwekar SU. Calciphylaxis: a rare but fatal delayed complication of Roux-en-Y gastric bypass surgery. Am J Kidney Dis. 2014 Aug; 64(2):274-7. PMID: 24787764.
    Citations: 6     Fields:    Translation:Humans
  63. Nigwekar SU, Tamez H, Thadhani RI. Vitamin D and chronic kidney disease-mineral bone disease (CKD-MBD). Bonekey Rep. 2014; 3:498. PMID: 24605215.
    Citations: 11     
  64. Palmer SC, Navaneethan SD, Craig JC, Perkovic V, Johnson DW, Nigwekar SU, Hegbrant J, Strippoli GF. HMG CoA reductase inhibitors (statins) for kidney transplant recipients. Cochrane Database Syst Rev. 2014 Jan 28; (1):CD005019. PMID: 24470059.
    Citations: 11     Fields:    Translation:Humans
  65. Nigwekar SU, Thadhani R. Vitamin D receptor activation: cardiovascular and renal implications. Kidney Int Suppl (2011). 2013 Dec; 3(5):427-430. PMID: 25019025.
    Citations: 7     
  66. Palmer SC, Navaneethan SD, Craig JC, Johnson DW, Perkovic V, Nigwekar SU, Hegbrant J, Strippoli GF. HMG CoA reductase inhibitors (statins) for dialysis patients. Cochrane Database Syst Rev. 2013 Sep 11; (9):CD004289. PMID: 24022428.
    Citations: 18     Fields:    Translation:Humans
  67. Strazzula L, Nigwekar SU, Steele D, Tsiaras W, Sise M, Bis S, Smith GP, Kroshinsky D. Intralesional sodium thiosulfate for the treatment of calciphylaxis. JAMA Dermatol. 2013 Aug; 149(8):946-9. PMID: 23760631.
    Citations: 13     Fields:    Translation:Humans
  68. Nigwekar SU, Kulkarni H, Thakar CV. Natriuretic peptides in the management of solid organ transplantation associated acute kidney injury: a systematic review and meta-analysis. Int J Nephrol. 2013; 2013:949357. PMID: 23762556.
    Citations:    
  69. Nigwekar SU, Wenger J, Thadhani R, Bhan I. Hyponatremia, mineral metabolism, and mortality in incident maintenance hemodialysis patients: a cohort study. Am J Kidney Dis. 2013 Oct; 62(4):755-62. PMID: 23591291.
    Citations: 14     Fields:    Translation:Humans
  70. Nigwekar SU, Bhan I, Turchin A, Skentzos SC, Hajhosseiny R, Steele D, Nazarian RM, Wenger J, Parikh S, Karumanchi A, Thadhani R. Statin use and calcific uremic arteriolopathy: a matched case-control study. Am J Nephrol. 2013; 37(4):325-32. PMID: 23548843.
    Citations: 17     Fields:    Translation:Humans
  71. Nigwekar SU, Brunelli SM, Meade D, Wang W, Hymes J, Lacson E. Sodium thiosulfate therapy for calcific uremic arteriolopathy. Clin J Am Soc Nephrol. 2013 Jul; 8(7):1162-70. PMID: 23520041.
    Citations: 30     Fields:    Translation:Humans
  72. Nigwekar SU, Thadhani RI. Shining light on vitamin D trials in chronic kidney disease. Kidney Int. 2013 Feb; 83(2):198-200. PMID: 23364588.
    Citations:    Fields:    Translation:Humans
  73. Nigwekar SU, Strippoli GF, Navaneethan SD. Thyroid hormones for acute kidney injury. Cochrane Database Syst Rev. 2013 Jan 31; (1):CD006740. PMID: 23440810.
    Citations: 1     Fields:    Translation:Humans
  74. Jardine MJ, Kang A, Zoungas S, Navaneethan SD, Ninomiya T, Nigwekar SU, Gallagher MP, Cass A, Strippoli G, Perkovic V. The effect of folic acid based homocysteine lowering on cardiovascular events in people with kidney disease: systematic review and meta-analysis. BMJ. 2012 Jun 13; 344:e3533. PMID: 22695899.
    Citations: 19     Fields:    Translation:Humans
  75. Nigwekar SU, Bhan I, Thadhani R. Ergocalciferol and cholecalciferol in CKD. Am J Kidney Dis. 2012 Jul; 60(1):139-56. PMID: 22560832.
    Citations: 27     Fields:    Translation:Humans
  76. Nigwekar SU, Waikar SS. Diuretics in acute kidney injury. Semin Nephrol. 2011 Nov; 31(6):523-34. PMID: 22099509.
    Citations: 4     Fields:    Translation:Humans
  77. Chawla A, Sterns RH, Nigwekar SU, Cappuccio JD. Mortality and serum sodium: do patients die from or with hyponatremia? Clin J Am Soc Nephrol. 2011 May; 6(5):960-5. PMID: 21441132.
    Citations: 35     Fields:    Translation:Humans
  78. Nigwekar SU, Bhan I, Thadhani R. Nutritional vitamin D in dialysis patients: what to D-iscern? Nephrol Dial Transplant. 2011 Mar; 26(3):764-6. PMID: 21239385.
    Citations: 4     Fields:    Translation:Humans
  79. Sutton J, Nigwekar S. Top 5 Questions to Ask Your Doctor. 2010. View Publication.
  80. Park M, Coca SG, Nigwekar SU, Garg AX, Garwood S, Parikh CR. Prevention and treatment of acute kidney injury in patients undergoing cardiac surgery: a systematic review. Am J Nephrol. 2010; 31(5):408-18. PMID: 20375494.
    Citations: 17     Fields:    Translation:Humans
  81. Nigwekar SU, Navaneethan SD, Parikh CR, Hix JK. Atrial natriuretic peptide for preventing and treating acute kidney injury. Cochrane Database Syst Rev. 2009 Oct 07; (4):CD006028. PMID: 19821351.
    Citations: 13     Fields:    Translation:Humans
  82. Navaneethan SD, Nigwekar SU, Perkovic V, Johnson DW, Craig JC, Strippoli GF. HMG CoA reductase inhibitors (statins) for dialysis patients. Cochrane Database Syst Rev. 2009 Jul 08; (3):CD004289. PMID: 19588351.
    Citations: 4     Fields:    Translation:Humans
  83. Navaneethan SD, Nigwekar SU, Sehgal AR, Strippoli GF. Aldosterone antagonists for preventing the progression of chronic kidney disease. Cochrane Database Syst Rev. 2009 Jul 08; (3):CD007004. PMID: 19588415.
    Citations: 12     Fields:    Translation:Humans
  84. Nigwekar SU, Kandula P, Hix JK, Thakar CV. Off-pump coronary artery bypass surgery and acute kidney injury: a meta-analysis of randomized and observational studies. Am J Kidney Dis. 2009 Sep; 54(3):413-23. PMID: 19406542.
    Citations: 23     Fields:    Translation:Humans
  85. Sterns RH, Nigwekar SU, Hix JK. The treatment of hyponatremia. Semin Nephrol. 2009 May; 29(3):282-99. PMID: 19523575.
    Citations: 43     Fields:    Translation:Humans
  86. Navaneethan SD, Perkovic V, Johnson DW, Nigwekar SU, Craig JC, Strippoli GF. HMG CoA reductase inhibitors (statins) for kidney transplant recipients. Cochrane Database Syst Rev. 2009 Apr 15; (2):CD005019. PMID: 19370615.
    Citations: 9     Fields:    Translation:Humans
  87. Navaneethan SD, Nigwekar SU, Perkovic V, Johnson DW, Craig JC, Strippoli GF. HMG CoA reductase inhibitors (statins) for dialysis patients. Cochrane Database Syst Rev. 2009 Apr 15; (2):CD004289. PMID: 19370598.
    Citations: 11     Fields:    Translation:Humans
  88. Beddhu S, Nigwekar SU, Ma X, Greene T. Associations of resting heart rate with insulin resistance, cardiovascular events and mortality in chronic kidney disease. Nephrol Dial Transplant. 2009 Aug; 24(8):2482-8. PMID: 19307229.
    Citations: 9     Fields:    Translation:Humans
  89. Navaneethan SD, Nigwekar SU, Sehgal AR, Strippoli GF. Aldosterone antagonists for preventing the progression of chronic kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol. 2009 Mar; 4(3):542-51. PMID: 19261819.
    Citations: 57     Fields:    Translation:Humans
  90. Nigwekar SU, Hix JK. The role of natriuretic peptide administration in cardiovascular surgery-associated renal dysfunction: a systematic review and meta-analysis of randomized controlled trials. J Cardiothorac Vasc Anesth. 2009 Apr; 23(2):151-60. PMID: 19167908.
    Citations: 5     Fields:    Translation:Humans
  91. Nigwekar SU, Kandula P. N-acetylcysteine in cardiovascular-surgery-associated renal failure: a meta-analysis. Ann Thorac Surg. 2009 Jan; 87(1):139-47. PMID: 19101287.
    Citations: 8     Fields:    Translation:HumansPHPublic Health
  92. Nigwekar SU, Navaneethan SD, Parikh CR, Hix JK. Atrial natriuretic peptide for management of acute kidney injury: a systematic review and meta-analysis. Clin J Am Soc Nephrol. 2009 Feb; 4(2):261-72. PMID: 19073785.
    Citations: 17     Fields:    Translation:Humans
  93. Navaneethan SD, Nigwekar SU. Lack of permanent access in late referrals and its implications: not to be forgotten. Am J Med. 2008 Jun; 121(6):e17; author reply e19. PMID: 18501211.
    Citations:    Fields:    Translation:Humans
  94. Nigwekar SU, Rajda J, Navaneethan SD. Hospitalist care and length of stay in patients with hip fracture: a systematic review. Arch Intern Med. 2008 May 12; 168(9):1010-1. PMID: 18474766.
    Citations: 4     Fields:    Translation:Humans
  95. Nigwekar SU, Wolf M, Sterns RH, Hix JK. Calciphylaxis from nonuremic causes: a systematic review. Clin J Am Soc Nephrol. 2008 Jul; 3(4):1139-43. PMID: 18417747.
    Citations: 62     Fields:    Translation:Humans
  96. Navaneethan SD, Jeevanantham V, Nigwekar SU. Prevalence and predictors of lack of permanent vascular access in early referrals. Am J Kidney Dis. 2007 Oct; 50(4):687. PMID: 17900473.
    Citations:    Fields:    Translation:Humans
  97. Nigwekar SU, Job AV, Kouides RW, Polashenski W. Effectiveness of hospitalist involvement in hip fracture management questioned. South Med J. 2007 Sep; 100(9):912-3. PMID: 17902295.
    Citations: 1     Fields:    Translation:Humans
  98. Nigwekar SU. An unusual case of nonhealing leg ulcer in a diabetic patient. South Med J. 2007 Aug; 100(8):851-2. PMID: 17713318.
    Citations: 9     Fields:    Translation:Humans
  99. Navaneethan SD, Nigwekar S, Sengodan M, Anand E, Kadam S, Jeevanantham V, Grieff M, Choudhry W. Referral to nephrologists for chronic kidney disease care: is non-diabetic kidney disease ignored? Nephron Clin Pract. 2007; 106(3):c113-8. PMID: 17522473.
    Citations: 14     Fields:    Translation:Humans
  100. Nigwekar SU, Navaneethan SD. Timely referral alone may not be enough for patients with chronic kidney disease. Mayo Clin Proc. 2007 Feb; 82(2):252-3. PMID: 17290737.
    Citations:    Fields:    Translation:Humans
  101. Nigwekar SU, Casey KJ. Atypical presentation of Crohn disease in an Asian-Indian patient. South Med J. 2006 Nov; 99(11):1310-1. PMID: 17195440.
    Citations:    Fields:    Translation:Humans
  102. Nigwekar SU, Morse DS. Educational half day: an innovative way to incorporate substance abuse curriculum into residency training. Subst Abus. 2006 Sep; 27(3):1-3. PMID: 17135174.
    Citations: 3     Fields:    Translation:Humans
  103. Dietrich J, Chow MY, Phelan J, Nigwekar SU. Metastatic primary peritoneal carcinoma presenting as tension hydrothorax. Lancet Oncol. 2006 Sep; 7(9):784. PMID: 16945776.
    Citations:    Fields:    Translation:Humans
  104. Nigwekar S. Medical Image. An unusual cause of abdominal pain. N Z Med J. 2006 Mar 31; 119(1231):U1908. PMID: 16582970.
    Citations:    Fields:    Translation:Humans
  105. Rao M, Nigwekar S. Medical image. Acute nephralgia. N Z Med J. 2005 Jun 03; 118(1216):U1503. PMID: 15937537.
    Citations:    Fields:    Translation:Humans
  106. Nigwekar SU, Casey KJ. Metronidazole-induced pancreatitis. A case report and review of literature. JOP. 2004 Nov 10; 5(6):516-9. PMID: 15536294.
    Citations: 4     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Nigwekar's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (348)
Explore
_
Co-Authors (65)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.